# Highlights of ASCO 2025

**Authors:** Brandon DaSilva, Alfred I Neugut, Tito Fojo, Susan E Bates

PMC · DOI: 10.1093/oncolo/oyaf336 · The Oncologist · 2025-10-07

## Full-text entities

- **Genes:** CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, GPRC5D (G protein-coupled receptor class C group 5 member D) [NCBI Gene 55507], IL13RA2 (interleukin 13 receptor subunit alpha 2) [NCBI Gene 3598] {aka CD213A2, CT19, IL-13R, IL13BP}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, HAMP (hepcidin antimicrobial peptide) [NCBI Gene 57817] {aka HEPC, HFE2B, LEAP1, PLTR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, TACSTD2 (tumor associated calcium signal transducer 2) [NCBI Gene 4070] {aka EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1}, TNFRSF17 (TNF receptor superfamily member 17) [NCBI Gene 608] {aka BCM, BCMA, CD269, TNFRSF13A}, TRANK1 (tetratricopeptide repeat and ankyrin repeat containing 1) [NCBI Gene 9881] {aka LBA1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}
- **Diseases:** renal cell cancer (MESH:D002292), CRC (MESH:D015179), multiple (MESH:D009104), diarrhea (MESH:D003967), pneumonia (MESH:D011014), triple-negative breast cancer (MESH:D064726), Breast cancer (MESH:D001943), metastasis (MESH:D009362), alopecia (MESH:D000505), nausea (MESH:D009325), cytokine release syndrome (MESH:D000080424), death (MESH:D003643), gastric/gastro-esophageal junction (GEJ) adenocarcinoma (MESH:D005764), rectal cancer (MESH:D012004), Cancer (MESH:D009369), melanoma (MESH:D008545), ICANS (MESH:C000722498), Fatigue (MESH:D005221), Lung cancer (MESH:D008175), neurotoxicity (MESH:D020258), Head and neck cancer (MESH:D006258), toxicities (MESH:D064420), Gastric cancer (MESH:D013274), bladder cancer (MESH:D001749), infections (MESH:D007239), solid (MESH:D018250), polycythemia vera (MESH:D011087), small-cell lung cancer (MESH:D055752), colon adenocarcinoma (MESH:D003110), cSCC (MESH:D002294), NSCLC (MESH:D002289), glioblastoma multiforme (MESH:D005909), vomiting (MESH:D014839), HNSCC (MESH:D000077195), multiple myeloma (MESH:D009101), thrombotic (MESH:D013927)
- **Chemicals:** atezolizumab (MESH:C000594389), carboplatin (MESH:D016190), tipiracil (MESH:C000613754), gemcitabine (MESH:D000093542), irinotecan (MESH:D000077146), cetuximab (MESH:D000068818), docetaxel (MESH:D000077143), cisplatin (MESH:D002945), Adagrasib (MESH:C000718190), CAR-T (-), camizestrant (MESH:C000722187), apatinib (MESH:C553458), Encorafenib (MESH:C000601108), paclitaxel (MESH:D017239), durvalumab (MESH:C000613593), cemiplimab (MESH:C000627974), fulvestrant (MESH:D000077267), ramucirumab (MESH:C543333), oxaliplatin (MESH:D000077150), cel (MESH:C054688), trifluridine (MESH:D014271), pembrolizumab (MESH:C582435), nivolumab (MESH:D000077594), platinum (MESH:D010984), zolbetuximab (MESH:C585662), taxane (MESH:C080625), fruquintinib (MESH:C000591844)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** V600E, G12C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12605717/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12605717/full.md

---
Source: https://tomesphere.com/paper/PMC12605717